Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA600870
Max Phase: Preclinical
Molecular Formula: C84H119N29O13
Molecular Weight: 1743.07
Molecule Type: Protein
Associated Items:
ID: ALA600870
Max Phase: Preclinical
Molecular Formula: C84H119N29O13
Molecular Weight: 1743.07
Molecule Type: Protein
Associated Items:
Canonical SMILES: N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCNC(=N)N)C(N)=O
Standard InChI: InChI=1S/C84H119N29O13/c85-33-11-9-25-60(107-78(123)65(38-46-42-100-55-21-5-1-16-50(46)55)111-76(121)63(29-31-69(88)114)105-72(117)54(87)20-13-35-97-82(91)92)74(119)106-61(26-10-12-34-86)75(120)110-68(41-49-45-103-58-24-8-4-19-53(49)58)81(126)113-67(40-48-44-102-57-23-7-3-18-52(48)57)80(125)109-64(30-32-70(89)115)77(122)112-66(39-47-43-101-56-22-6-2-17-51(47)56)79(124)108-62(28-15-37-99-84(95)96)73(118)104-59(71(90)116)27-14-36-98-83(93)94/h1-8,16-19,21-24,42-45,54,59-68,100-103H,9-15,20,25-41,85-87H2,(H2,88,114)(H2,89,115)(H2,90,116)(H,104,118)(H,105,117)(H,106,119)(H,107,123)(H,108,124)(H,109,125)(H,110,120)(H,111,121)(H,112,122)(H,113,126)(H4,91,92,97)(H4,93,94,98)(H4,95,96,99)/t54-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-/m0/s1
Standard InChI Key: AMFGVYJINCFHNR-ADQNHEFQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1743.07 | Molecular Weight (Monoisotopic): 1741.9542 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Garibotto FM, Garro AD, Masman MF, Rodríguez AM, Luiten PG, Raimondi M, Zacchino SA, Somlai C, Penke B, Enriz RD.. (2010) New small-size peptides possessing antifungal activity., 18 (1): [PMID:19959366] [10.1016/j.bmc.2009.11.009] |
Source(1):